Diabetic neuropathy: cellular mechanisms as therapeutic targets (Q37930962)

25 August 2017

1 reference

title

Diabetic neuropathy: cellular mechanisms as therapeutic targets (English)

1 reference

25 August 2017

1 reference

4

Eva L Feldman

1 reference

25 August 2017

Andrea M Vincent

1

1 reference

25 August 2017

Brian C Callaghan

series ordinal

2

1 reference

25 August 2017

Andrea L Smith

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

13 September 2011

1 reference

25 August 2017

Nature Reviews Neurology

1 reference

25 August 2017

7

1 reference

25 August 2017

10

1 reference

25 August 2017

573-583

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.137

25 August 2017

0 references

cites work

Diabetic neuropathy: mechanisms to management

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Diabetic painful and insensate neuropathy: pathogenesis and potential treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Open calcaneal fractures in diabetic patients with neuropathy: a report of three cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Diabetes causes an early reduction in autonomic ganglion blood flow in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Angiogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Sensory neurons with activated caspase-3 survive long-term experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oxidative stress in the pathogenesis of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

New insights into the mechanisms of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Regulation of brain glucose transporters by glucose and oxygen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oxidative damage during aging targets mitochondrial aconitase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effects of Elevated Glucose Concentrations on the Metabolism of the Aortic Wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Diabetes and the peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The multifaceted therapeutic potential of benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Hyperlipidemia: a new therapeutic target for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Residual microvascular risk in diabetes: unmet needs and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Elevated triglycerides correlate with progression of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Cell cycle regulation via inter-nuclear communication during the early embryonic development of Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Diabetes, hyperglycemia and accelerated atherosclerosis: evidence supporting a role for endoplasmic reticulum (ER) stress signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Lipotoxicity-mediated cell dysfunction and death involve lysosomal membrane permeabilization and cathepsin L activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Elevated Free Fatty Acids Attenuate the Insulin-Induced Suppression of PDK4 Gene Expression in Human Skeletal Muscle: Potential Role of Intramuscular Long-Chain Acyl-Coenzyme A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-κB and Akt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

How does diabetes accelerate Alzheimer disease pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Impaired glucose tolerance and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Acute elevation of circulating fatty acids impairs downstream insulin signalling in rat skeletal muscle in vivo independent of effects on stress signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Metabolic memory: a vascular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

New perspectives on the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Apoptosis in acute and chronic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Neurons undergo apoptosis in animal and cell culture models of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Neuronal preservation in the sympathetic ganglia of rats with chronic streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

PARP inhibitors for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Apocynin decreases hydrogen peroxide and nitrate concentrations in exhaled breath in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Sciatic nerve of diabetic rat treated with epoetin delta: effects on C-fibers and blood vessels including pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Modulation of coronary autoregulatory responses by endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effect of L-arginine on the microcirculation in the neuropathic diabetic foot in Type 2 diabetes mellitus: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The involvement of aldose reductase in alterations to neurotrophin receptors and neuronal cytoskeletal protein mRNA levels in the dorsal root ganglion of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Ranirestat for the management of diabetic sensorimotor polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Alpha-lipoic Acid and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Fibrates and microvascular complications in diabetes--insight from the FIELD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Use of anticonvulsants for treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The effects of cilostazol on peripheral neuropathy in diabetic patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Cellular and physiological effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Nerve growth factor administration protects against experimental diabetic sensory neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Ruboxistaurin: PKC-beta inhibition for complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Pathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular an

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Factors That Impact Symptomatic Diabetic Peripheral Neuropathy in Placebo-Administered Patients From Two 1-Year Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The laterality index in the evaluation of distal sensorimotor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Short-term hyperglycemia produces oxidative damage and apoptosis in neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Lipid glycation and protein glycation in diabetes and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Oxidized low-density lipoprotein (oxLDL)-induced cell death in dorsal root ganglion cell cultures depends not on the lectin-like oxLDL receptor-1 but on the toll-like receptor-4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Duloxetine for treating painful neuropathy or chronic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Pregabalin for acute and chronic pain in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Antidepressants for neuropathic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Anticonvulsant drugs for acute and chronic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Elimination of the delayed postischemic energy deficit in cerebral cortex and hippocampus of aged rats with a dried, deproteinized blood extract (Actovegin)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

Clinical testing in diabetic peripheral neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.137

High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels

31 March 2020

1 reference

12 December 2020

PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapy

1 reference

12 December 2020

Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats

1 reference

12 December 2020

Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer

1 reference

12 December 2020

Pathology and functional diagnosis of small-fiber painful neuropathy.

1 reference

12 December 2020

Comparison of nerve conduction studies with diabetic neuropathy symptom score and diabetic neuropathy examination score in type-2 diabetics for detection of sensorimotor polyneuropathy

1 reference

12 December 2020

Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

1 reference

12 December 2020

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

1 reference

12 December 2020

Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: effects of the antioxidant stobadine in comparison with a high-dose alpha-lipoic acid treatment.

1 reference

12 December 2020

A comparison of sciatic nerve neuropathy in diabetic and aged rats

1 reference

12 December 2020

Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitus.

1 reference

12 December 2020

A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.

1 reference

12 December 2020

10.1038/NRNEUROL.2011.137

Identifiers

DOI

1 reference

25 August 2017

1 reference